Endoscopic sleeve gastroplasty (ESG) for morbid obesity: how effective is it?

Lopez-Nava, Gontrand; Laster, Janese; Negi, Anuradha; Fook-Chong, Stephanie; BAUTISTA-CASTAÑO, I; Asokkumar, Ravishankar

doi:10.1007/s00464-021-08289-1

Record: found
Abstract: not found
Article: not found

Endoscopic sleeve gastroplasty (ESG) for morbid obesity: how effective is it?

Author(s): Gontrand Lopez-Nava , Janese Laster , Anuradha Negi , Stephanie Fook-Chong , I. Bautista-Castaño , Ravishankar Asokkumar

Publication date (Electronic): January 25 2021

Journal: Surgical Endoscopy

Publisher: Springer Science and Business Media LLC

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

ESG is an effective treatment for classes I and II obesity. However, the benefit of ESG in patients with morbid obesity (BMI ≥ 40 kg/m2) who decline surgery is not known. The study aims to compare the effectiveness and safety of ESG in all three obesity classes at 1 year.